3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
6
Completed
5
Active not recruiting
5
Recruiting
3
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
4
Breast
3
Head & Neck
2
Tumor-Agnostic
1
Plasma cell
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Cytoreductive Surgery
1
Interventions
Paclitaxel
20
Carboplatin
20
Bevacizumab
13
Radiotherapy
12
Cisplatin
11
Cyclophosphamide
8
olaparib
6
niraparib
6
Taxes
6
pembrolizumab
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
Biopsy
5
talazoparib
4
dostarlimab
4
aldesleukin
4
Specimen Handling
4
Fulvestrant
4
Doxorubicin
4
fludarabine
3
atezolizumab
3
Topotecan
3
Radiation
3
NVP-BKM120
3
Methods
3
Metformin
3
Letrozole
3
Hyperthermic Intraperitoneal Chemotherapy
3
Early Intervention, Educational
3
Colposcopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Fluorodeoxyglucose F18
×
Gynecologic
×
Clear all
NCT05390021
2024-04-02
PET/MRI in Endometrial Cancer
Massachusetts General Hospital
Phase NA
Withdrawn